immuneAdvice GmbH

immuneAdvice GmbH is a dynamic biotechnology research company focused on revolutionizing immunotherapy through innovative solutions. Specializing in the development of immune cell tracers (ICE-Ts), immuneAdvice GmbH is dedicated to the non-invasive detection of immune cells within the body. This cutting-edge technology aims to significantly enhance the predictability and effectiveness of immunotherapies, addressing the critical need for patient stratification in cancer treatment.

Located in Reutlingen/ Tübingen, DE, immuneAdvice GmbH is at the forefront of creating single domain antibody (VHHs)-based novel tracer molecules. These ICE-Ts are designed to visualize the dynamic distribution and activation state of immune cells with exceptional spatial and temporal resolution. By providing individualized assessments of immunotherapy responses, immuneAdvice GmbH seeks to establish a therapeutic diagnostic that can predict the efficacy of both current and future immunotherapies, as well as evaluate their progress during treatment.

immuneAdvice GmbH's commitment to innovation and excellence positions it as a key player in the advancement of personalized medicine. The company is actively working towards initiating its first human trial in 2025, further solidifying its role in shaping the future of cancer treatment. We invite the manager of immuneAdvice GmbH to create a customized and exclusive company showcase and product listing on our platform to highlight your groundbreaking work.